Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02881515 · ClinicalTrials.gov registry record · NA

Adverse Neurogenic Actions of Dietary Salt

A NA study of Blood Pressure, sponsored by University of Delaware.

Completed
Registry status
NA
Development phase
77
Enrollment target
1
Study location

NCT02881515 is a NA study of Blood Pressure that has completed, run by University of Delaware. The registered enrollment target is 77 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02881515, a NA study of Blood Pressure, has completed, sponsored by University of Delaware.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target
1
Study location

Study Summary

Excess dietary salt increases the risk for cardiovascular events, even in people that are not hypertensive. There is some evidence that excess dietary salt exaggerates blood pressure and sympathetic nervous system responses to various perturbations and increases blood pressure variability. This proposal will examine the effects of low, medium, and high salt diets on cardiovascular reactivity and blood pressure variability.

Conditions Studied

Interventions

  • OTHER Low Sodium Diet
  • OTHER Medium Sodium Diet
  • OTHER High Sodium Diet

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2016-04
Est. Completion 2022-11-22
Phase NA

Sponsor

University of Delaware

106 total trials

What the Registry Record Tells You About NCT02881515

The ClinicalTrials.gov registry entry for NCT02881515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (73% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 3 interventions - of which Low Sodium Diet is the first listed.

NCT02881515 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT02881515 about?

NCT02881515 is a clinical study titled "Adverse Neurogenic Actions of Dietary Salt". Excess dietary salt increases the risk for cardiovascular events, even in people that are not hypertensive. There is some evidence that excess dietary salt exaggerates blood pressure and sympathetic nervous system responses to various perturbations and increases blood pressure variability. This prop...

What is the current status of trial NCT02881515?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2016-04. Estimated completion is 2022-11-22.

What conditions does trial NCT02881515 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT02881515?

The interventions under investigation include: Low Sodium Diet (OTHER), Medium Sodium Diet (OTHER), High Sodium Diet (OTHER).

Who is sponsoring clinical trial NCT02881515?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02881515 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.